Live webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis
Register now!Join this valuable and instructive webinar! Familiarise yourself with the robust European regulatory processes and effective oversight for generic, biosimilar, and follow-on non-biologic complex drugs (NBCDs) of disease modifying […]
ParadigMS presence at EAN
Messukeskus Expo Messuaukio 1, FinlandThe 10th Congress of the European Academy of Neurology (EAN) will take place in Helsinki, Finland (and online) from 29 June to 2 July 2024.The overarching theme for EAN 2024 […]
Expert Meeting 7th September 2024
On Saturday, 7th September, ParadigMS will convene an Expert Meeting in Budapest, assembling top specialists in multiple sclerosis to review and discuss educational materials on MS treatment and care.The detailed […]
Live webinar on the use of generic, biosimilar and non-biologic complex drugs for multiple sclerosis – Second edition – with German translation!
deutschRegisterJoin this webinar and familiarise yourself with the robust European regulatory processes and effective oversight for generic, biosimilar, and follow-on non-biologic complex drugs (NBCDs) of disease modifying therapies in multiple […]
ParadigMS Pre-MENACTRIMS Symposium 2024
Join us at ParadigMS Pre-MENACTRIMS Symposium!Thursday, 31st October 2024, Jeddah, Saudi ArabiaWe are thrilled to invite you to our upcoming symposium, featuring the latest insights into multiple sclerosis (MS) management […]
Live Webinar on MS Prognosis Scorecard: A Tool for Predicting Clinical Outcomes
Multiple sclerosis (MS) presents neurologists with a unique set of challenges, as the disease's clinical course is highly variable from patient to patient. This makes it difficult to predict progression, […]